Please assess the completion status of the following clinical trial:

Trial Title: Lid Wiper Epitheliopathy Trial

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: DOUBLE
- Phase: None
- Number of Arms: 4.0

Eligibility Criteria:
Inclusion Criteria:~* Sign Informed Consent document.~* Severe lid wiper epitheliopathy (upper lid) in either eye.~* Currently wearing spherical daily disposable soft contact lenses or daily wear soft contact lenses in both eyes with at least 3 months of contact lens wearing experience.~* Symptomatic as determined by the SPEED questionnaire.~* Willing to follow visit schedule.~* Habitual contact lens power with the range of -1.00 to -6.00 diopters (D) with best corrected distance visual acuity greater than or equal to 20/25 in each eye.~* Astigmatism less than or equal to 0.75D.~* Possess spectacles which provide visual acuity of at least 20/25 in each eye.~* Willing and able to complete daily diaries.~* Other protocol-defined inclusion criteria may apply.~Exclusion Criteria:~* Eye injury within 12 weeks immediately prior to enrollment.~* Any ocular condition that would contraindicate contact lens wear.~* Any use of systemic or ocular medications that would contraindicate contact lens wear, as determined by the investigator.~* Currently wearing toric or multifocal soft contact lenses.~* Participation in a clinical study (including contact lens or contact lens care product) within the previous 30 days.~* Routinely sleeps in lenses for at least 1 night per week.~* Other protocol-defined exclusion criteria may apply.

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- Spectacles, Stage 1 (Type: EXPERIMENTAL): Spectacles per participant's habitual perscription worn for 2 weeks
- 1-DAY ACUVUE, Stage 1 (Type: ACTIVE_COMPARATOR): Etafilcon A contact lenses worn in both eyes at least 5 days per week, at least 6 hours per day, for 2 weeks in a daily disposable mode
- DAILIES TOTAL1, Stage 2 (Type: EXPERIMENTAL): Delefilcon A contact lenses worn in both eyes at least 5 days per week, at least 6 hours per day, for 2 weeks in a daily disposable mode
- 1-DAY ACUVUE, Stage 2 (Type: ACTIVE_COMPARATOR): Etafilcon A contact lenses worn in both eyes at least 5 days per week, at least 6 hours per day, for 2 weeks in a daily disposable mode

Based on this trial design, predict the completion outcome and termination type (if applicable).